Crystal-associated arthritis in the elderly.
Since the original recognition of these conditions in 1961, a great deal has been learned about the pathogenesis, clinical manifestations, and appropriate treatment of gout and pseudogout, and the role of crystals in osteoarthritis has been further defined. The variable manifestations of crystal-induced arthritis in elderly populations has led to a greater need for proper diagnosis and treatment strategies for these increasingly common forms of arthritis.
Wise
Christopher M
CM
Internal Medicine, Division of Rheumatology, Allergy, and Immunology, Medical College of Virginia, Virginia Commonwealth University Health System, 417 North 11th Street, Box 980647, Richmond, VA 23298, USA. cmwise@hsc.vcu.edu
D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use; D001168:Arthritis / Q000175:diagnosis / Q000503:physiopathology*; D015210:Arthritis, Gouty / Q000175:diagnosis / Q000453:epidemiology; D002131:Calcium Pyrophosphate; D002805:Chondrocalcinosis / Q000175:diagnosis / Q000503:physiopathology; D015897:Comorbidity; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000627:therapeutic use; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000503:physiopathology; D010003:Osteoarthritis / Q000175:diagnosis; D051437:Renal Insufficiency / Q000453:epidemiology; D014527:Uric Acid
D005938:Glucocorticoids; D006074:Gout Suppressants; D014527:Uric Acid; D000493:Allopurinol; D002131:Calcium Pyrophosphate